Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of drugs targeting the central nervous system, such as antipsychotics and antidepressants. Its molecular structure, featuring a 4-methylpiperazin-1-yl group, enhances binding affinity to CNS receptors. Also employed in the creation of compounds with potential antimicrobial, anti-inflammatory, and anti-cancer properties, where structural modifications can improve specificity, such as against cancer cells. Plays a role in organic chemistry research for constructing complex molecules with therapeutic applications.